MYCN and neuroblastoma: The MYCN proto-oncogene plays an important role in neuroblastoma development; about 30%-40% of advanced stage tumors exhibit MYCN amplification, which has been correlated to rapid tumor progression, drug resistance and poor outcome [49, 50].